Table I.
Patient demographics and comorbidities in patients with and without metabolic syndrome following TSA.
| Characteristic | No metabolic syndrome |
Metabolic syndrome |
P value | ||
|---|---|---|---|---|---|
| Number | Percent | Number | Percent | ||
| Total | 23,717 | 100.0% | 2896 | 100.0% | |
| Age | |||||
| 18-39 | 4 | 0.02% | 140 | 4.8% | .001 |
| 40-64 | 6574 | 27.7% | 744 | 25.7% | <.001 |
| 65-74 | 9703 | 40.9% | 1420 | 49.0% | – |
| ≥75 | 7300 | 30.8% | 728 | 25.1% | <.001 |
| Gender | .017 | ||||
| Female | 13,147 | 55.4% | 1673 | 57.8% | |
| Male | 10,570 | 44.6% | 1223 | 42.2% | |
| Body mass index (kg/m2) | |||||
| >18.5 | 195 | 0.83% | 0 | 0.00% | 1.000 |
| 18.5-30.0 | 12,704 | 53.6% | 0 | 0.00% | – |
| 30.1-34.9 | 5878 | 24.8% | 1224 | 42.3% | .956 |
| 35-39.9 | 2895 | 12.2% | 891 | 30.8% | .955 |
| ≥40 | 2045 | 8.6% | 781 | 26.9% | .955 |
| ASA classification | <.001 | ||||
| 1-2 | 10,867 | 45.8% | 421 | 14.5% | |
| ≥ 3 | 12,850 | 54.2% | 2475 | 85.5% | |
| Functional status | <.001 | ||||
| Independent | 23,248 | 98.0% | 2798 | 96.6% | |
| Dependent | 469 | 1.9% | 98 | 3.4% | |
| Current smoker | <.001 | ||||
| No | 21,201 | 89.4% | 2663 | 92.0% | |
| Yes | 2516 | 10.6% | 233 | 8.0% | |
| Diabetes | |||||
| No | 21,803 | 91.9% | 0 | 0.0% | – |
| Noninsulin | 1442 | 6.1% | 1978 | 68.3% | .937 |
| Insulin | 472 | 1.9% | 918 | 31.7% | .936 |
| Dyspnea | |||||
| No | 22,226 | 93.7% | 2592 | 89.5% | – |
| Moderate exertion | 1424 | 6.0% | 290 | 10.0% | <.001 |
| At rest | 67 | 0.3% | 14 | 0.5% | .048 |
| COPD | <.001 | ||||
| No | 22,192 | 93.6% | 2650 | 91.5% | |
| Yes | 1525 | 6.4% | 246 | 8.5% | |
| Ascites | .999 | ||||
| No | 23,713 | 99.9% | 2896 | 100.0% | |
| Yes | 4 | 0.02% | 0 | 0.0% | |
| CHF | <.001 | ||||
| No | 23,581 | 99.4% | 2855 | 98.6% | |
| Yes | 136 | 0.6% | 41 | 1.4% | |
| Hypertension | .963 | ||||
| No | 8921 | 37.6% | 0 | 0.0% | |
| Yes | 14,796 | 62.4% | 2896 | 100.0% | |
| On dialysis | .824 | ||||
| No | 23,641 | 99.7% | 2886 | 99.7% | |
| Yes | 76 | 0.3% | 10 | 0.3% | |
| Disseminated cancer | .269 | ||||
| No | 23,659 | 99.8% | 2892 | 99.9% | |
| Yes | 58 | 0.2% | 4 | 0.1% | |
| Open wound/wound infection | .013 | ||||
| No | 23,640 | 99.7% | 2878 | 99.4% | |
| Yes | 77 | 0.3% | 18 | 0.6% | |
| 10% weight loss | .995 | ||||
| No | 23,668 | 99.8% | 2890 | 99.8% | |
| Yes | 49 | 0.2% | 6 | 0.2% | |
| Bleeding disorders | .004 | ||||
| No | 23,143 | 97.6% | 2800 | 96.7% | |
| Yes | 574 | 2.4% | 96 | 3.3% | |
| Chronic steroid use | .228 | ||||
| No | 22,556 | 95.1% | 2769 | 95.6% | |
| Yes | 1161 | 4.9% | 127 | 4.4% | |
| Preoperative transfusion | .11 | ||||
| No | 23,670 | 99.8% | 2886 | 99.5% | |
| Yes | 47 | 0.2% | 10 | 0.5% | |
| Total operative time | |||||
| 0-79 | 6072 | 25.6% | 710 | 24.5% | .574 |
| 80-128 | 11,800 | 49.8% | 1418 | 49.0% | – |
| ≥129 | 5845 | 24.6% | 768 | 26.5% | .060 |
TSA, total shoulder arthroplasty; ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure.
Bold P value indicates statistical significance with P value set to <.05.